Metabolic Regulation of the Intestinal Mucosal Interface in Obesity-Associated Colorectal Carcinogenesis: Mechanisms, Biomarkers, and Therapeutic Opportunities

The global rise in obesity has paralleled an increasing incidence of colorectal cancer (CRC), particularly early-onset CRC, highlighting the need to better understand the mechanisms linking metabolic dysfunction to colorectal carcinogenesis. While chronic inflammation and gut microbial dysbiosis are recognized contributors, the biological processes integrating systemic metabolic alterations with local intestinal pathology remain incompletely understood. In this review, we propose the intestinal mucosal interface as the central biological platform through which obesity promotes CRC development. We describe how obesity-associated alterations in adipokine secretion, insulin/insulin-like growth factor-1 (IGF-1) signaling, bile acid metabolism, and chronic inflammation disrupt epithelial barrier integrity, goblet-cell function, intestinal stem-cell regulation, mucosal immunity, and host–microbiota interactions. Collectively, these changes create a metabolically altered microenvironment that favors epithelial transformation and early colorectal carcinogenesis. We also discuss emerging biomarkers that reflect metabolic, epithelial, microbial, and immune dysfunction, together with therapeutic strategies aimed at restoring intestinal homeostasis through metabolic intervention, microbiota modulation, and immune-targeted approaches. This integrated framework extends the traditional barrier–microbiota–inflammation model and identifies the intestinal mucosal interface as a promising target for risk stratification, early detection, prevention, and precision therapy in obesity-driven CRC.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2026-11-13
DOI
https://doi.org/10.3390/cancers18223638
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Metabolic Regulation of the Intestinal Mucosal Interface in Obesity-Associated Colorectal Carcinogenesis: Mechanisms, Biomarkers, and Therapeutic Opportunities

Vijay Morampudi, Merlinsheeba Gali Ligory, Yasaswi Khaderbad, V. V. Ravikanth Vishnubhotla
4 links
Cancers
Gut microbiota and health
article

Metabolic Regulation of the Intestinal Mucosal Interface in Obesity-Associated Colorectal Carcinogenesis: Mechanisms, Biomarkers, and Therapeutic Opportunities

Vijay Morampudi, Merlinsheeba Gali Ligory, Yasaswi Khaderbad, V. V. Ravikanth Vishnubhotla
article en

Abstract

The global rise in obesity has paralleled an increasing incidence of colorectal cancer (CRC), particularly early-onset CRC, highlighting the need to better understand the mechanisms linking metabolic dysfunction to colorectal carcinogenesis. While chronic inflammation and gut microbial dysbiosis are recognized contributors, the biological processes integrating systemic metabolic alterations with local intestinal pathology remain incompletely understood. In this review, we propose the intestinal mucosal interface as the central biological platform through which obesity promotes CRC development. We describe how obesity-associated alterations in adipokine secretion, insulin/insulin-like growth factor-1 (IGF-1) signaling, bile acid metabolism, and chronic inflammation disrupt epithelial barrier integrity, goblet-cell function, intestinal stem-cell regulation, mucosal immunity, and host–microbiota interactions. Collectively, these changes create a metabolically altered microenvironment that favors epithelial transformation and early colorectal carcinogenesis. We also discuss emerging biomarkers that reflect metabolic, epithelial, microbial, and immune dysfunction, together with therapeutic strategies aimed at restoring intestinal homeostasis through metabolic intervention, microbiota modulation, and immune-targeted approaches. This integrated framework extends the traditional barrier–microbiota–inflammation model and identifies the intestinal mucosal interface as a promising target for risk stratification, early detection, prevention, and precision therapy in obesity-driven CRC.

CancersVol. 18(22)
University of Hyderabad (IN), Asian Institute of Gastroenterology (IN)
Indian Council of Medical Research, Science and Engineering Research Board
Good health and well-being
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon